Zombie trials are often monocentric and cluster within fabricated evidence factories: a cohort study of 236 retracted randomized controlled trials with confirmed data fabrication
This cohort study of 236 retracted randomized controlled trials reveals that "zombie" trials with confirmed data fabrication are predominantly monocentric, concentrated in specific countries like Japan, and generated by a small number of repeat offenders operating in localized "factories" that cause long-delayed retraction cascades.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Imagine the library of human knowledge as a massive, bustling city. In this city, Randomized Controlled Trials (RCTs) are the gold-standard skyscrapers. They are the most reliable buildings we have for figuring out what medical treatments actually work and what doesn't. Scientists build these skyscrapers to guide doctors on how to treat patients, and they are the foundation of "evidence-based medicine." But, like any city, this one has a problem: sometimes, people build fake skyscrapers. These aren't just poorly built; they are entirely made of cardboard and paint, with no real structure inside. In the scientific world, these are called "zombie trials." They are studies that look real on the outside but are built on fabricated data—numbers made up out of thin air, like a story with no truth. These fake studies are dangerous because they can sneak into the city's blueprints, tricking doctors into prescribing treatments that don't work or could even be harmful. The big question researchers have always asked is: Who builds these fake buildings, where do they hide, and how do we spot them before they collapse?
This paper is a massive detective story that went hunting for these "zombie" skyscrapers. The authors, a team of researchers from France, the US, and beyond, decided to investigate a specific group of fake studies: those that had already been caught and officially pulled down (retracted) because their data was confirmed to be made up. They didn't just guess; they dug through a database of over 1,300 retracted medical trials and used a digital "metal detector" (text-mining) to find the 236 that were definitely built on lies.
What they found was a bit like discovering that most of the fake buildings in the city were constructed by a very small, very specific group of "super-fraudsters." Here are the key clues they uncovered:
- The "Super-Repeaters": The study found that 83.5% of these fake trials were linked to authors who had a history of getting caught multiple times. It wasn't a one-time mistake; it was a pattern. One single author, a man named Yoshitaka Fujii, was responsible for a staggering 104 of these fake trials (that's 43.8% of the entire group!). It's as if one person built nearly half of all the fake skyscrapers in the district.
- The "Factories": These fake trials weren't scattered randomly across the globe. They were clustered in specific "factories." The study found that 91.9% of these trials were monocentric, meaning they were all run from a single hospital or center, rather than many different places working together. This suggests that when a whole team works in one isolated place without outside eyes, it's easier to hide the fact that the data is fake.
- The "Anesthesia" Connection: The fake buildings were heavily concentrated in one specific neighborhood: Anesthesiology (the field of medicine dealing with sleep and pain during surgery). About 58.1% of these zombie trials were in this field. Furthermore, the country of Japan had the highest number of these fake trials, especially when you adjust for how many real trials they usually run.
- The "Time Travel" Problem: One of the scariest findings was how long it took to catch these frauds. For the authors who kept making fake trials over and over, it took a median of 13.6 years (that's over a decade!) between when they published the fake study and when it was finally retracted. For authors who only made one fake trial, it was much faster, at 2.75 years. This means the "super-fraudsters" were able to keep their fake skyscrapers standing, influencing medical decisions, for more than a decade before anyone pulled the plug.
- The "Cascade" Effect: When one of these fake trials was finally caught, it didn't just fall down alone. It often triggered a "cascade," like knocking over a line of dominoes. Once one fraud was exposed, it led investigators to dig up dozens of other fake papers by the same person, some published decades earlier. For example, catching one paper by Fujii in 2012 led to a massive cleanup that exposed fraud stretching back to the mid-1990s.
The paper also looked at the "blueprints" of these fake trials to see what red flags they shared. They found that these zombie trials often had small sample sizes (fewer patients), were rarely registered in official databases before they started (a sign of transparency), and often didn't say who paid for the research. They were also much more likely to be published in journals that might be "predatory" (journals that care more about money than quality), though many were still in respectable journals, showing that fraud can hide anywhere.
The authors are careful to say that while they found these patterns, they aren't saying that all trials from Japan or in Anesthesiology are fake. They are just pointing out that the fake ones they found were heavily concentrated there. They also admit that this is likely just the "tip of the iceberg." Because it takes so long to catch these frauds (over 13 years on average), there are probably many more fake trials out there right now that haven't been discovered yet.
In the end, this paper is a warning and a map. It shows us that scientific fraud isn't usually a random accident; it's often a systematic operation run by a few repeat offenders in isolated "factories." By understanding the shape of these fake studies—how they look, where they come from, and how long they hide—scientists hope to build better detectors (like a new tool called INSPECT-SR) to catch these "zombies" sooner, before they can trick the medical world and hurt patients. The goal is to make sure that when we build our medical skyscrapers, the foundations are real, not made of cardboard.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.